Wendy Hu

2.3k total citations
24 papers, 1.6k citations indexed

About

Wendy Hu is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Wendy Hu has authored 24 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 8 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Wendy Hu's work include Hematopoietic Stem Cell Transplantation (9 papers), Lymphoma Diagnosis and Treatment (6 papers) and Acute Lymphoblastic Leukemia research (4 papers). Wendy Hu is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), Lymphoma Diagnosis and Treatment (6 papers) and Acute Lymphoblastic Leukemia research (4 papers). Wendy Hu collaborates with scholars based in United States, Canada and Netherlands. Wendy Hu's co-authors include Karl G. Blume, Robert S. Negrin, Ruby M. Wong, Keith Stockerl‐Goldstein, Sandra J. Horning, Börje S. Andersson, Nelson J. Chao, Stephen J. Forman, Richard T. Hoppe and Gwynn D. Long and has published in prestigious journals such as Blood, Cancer and Cancer Research.

In The Last Decade

Wendy Hu

24 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wendy Hu United States	18	735	499	400	290	244	24	1.6k
Delvyn C. Case United States	17	666 0.9×	538 1.1×	511 1.3×	404 1.4×	179 0.7×	42	1.4k
R H Herzig United States	15	636 0.9×	368 0.7×	217 0.5×	325 1.1×	200 0.8×	27	1.1k
Masahito Tsurusawa Japan	22	390 0.5×	317 0.6×	306 0.8×	139 0.5×	434 1.8×	90	1.2k
Katsumichi Fujimaki Japan	19	419 0.6×	330 0.7×	303 0.8×	254 0.9×	123 0.5×	85	1.1k
Ho‐Jin Shin South Korea	22	944 1.3×	655 1.3×	691 1.7×	365 1.3×	192 0.8×	182	2.0k
Katsuji Shinagawa Japan	27	815 1.1×	548 1.1×	354 0.9×	259 0.9×	161 0.7×	108	1.9k
Ashwin Kashyap United States	11	1.2k 1.6×	530 1.1×	255 0.6×	272 0.9×	355 1.5×	13	1.8k
Carlos Panizo Spain	19	287 0.4×	463 0.9×	538 1.3×	398 1.4×	123 0.5×	93	1.5k
Myung Soo Hyun South Korea	18	424 0.6×	377 0.8×	195 0.5×	167 0.6×	137 0.6×	77	1.1k
Christine Devalck Belgium	22	756 1.0×	336 0.7×	373 0.9×	852 2.9×	105 0.4×	73	1.9k

Countries citing papers authored by Wendy Hu

Since Specialization

Citations

This map shows the geographic impact of Wendy Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Hu more than expected).

Fields of papers citing papers by Wendy Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Hu. The network helps show where Wendy Hu may publish in the future.

Co-authorship network of co-authors of Wendy Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Hu. A scholar is included among the top collaborators of Wendy Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Hu. Wendy Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hoff, Fieke W., Wendy Hu, Yihua Qiu, et al.. (2018). RPPA-Profiling Identifies Patients with Low Phosphorylation Levels of HSF1 at Serine 326 As Potential Candidate for Bortezomib Treatment in Addition to Standard Therapy in Pediatric Acute Myeloid Leukemia. Blood. 132(Supplement 1). 293–293. 2 indexed citations

Kashyap, Ashwin, John R. Wingard, Pablo J. Cagnoni, et al.. (2002). Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: Decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality. Biology of Blood and Marrow Transplantation. 8(9). 493–500. 172 indexed citations

Cao, Thai M., Sandra J. Horning, Robert S. Negrin, et al.. (2001). High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: The Stanford University experience. Biology of Blood and Marrow Transplantation. 7(5). 294–301. 59 indexed citations

Storb, Rainer, Karl G. Blume, Margaret O’Donnell, et al.. (2001). Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in four centers. Biology of Blood and Marrow Transplantation. 7(1). 39–45. 113 indexed citations

Johnston, Laura, Keith Stockerl‐Goldstein, Wendy Hu, et al.. (2000). Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma. Biology of Blood and Marrow Transplantation. 6(5). 555–562. 11 indexed citations

Andersson, Börje S., Timothy Madden, Hai T. Tran, et al.. (2000). Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: A phase I study. Biology of Blood and Marrow Transplantation. 6(5). 548–554. 121 indexed citations

Cairncross, Gregory, Lode J. Swinnen, Robert Bayer, et al.. (2000). Myeloablative chemotherapy for recurrent aggressiveoligodendroglioma. Neuro-Oncology. 2(2). 114–119. 27 indexed citations

Negrin, Robert S., K Atkinson, Tom Leemhuis, et al.. (2000). Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. Biology of Blood and Marrow Transplantation. 6(3). 262–271. 118 indexed citations

Wong, Ruby M., Robert S. Negrin, Judith A. Shizuru, et al.. (2000). Effect of Oral Glutamine Supplementation During Bone Marrow Transplantation. Journal of Parenteral and Enteral Nutrition. 24(2). 61–66. 77 indexed citations

10.

Stockerl‐Goldstein, Keith, Sunil Reddy, Sandra J. Horning, et al.. (2000). Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells. Biology of Blood and Marrow Transplantation. 6(5). 506–512. 54 indexed citations

11.

Alvarnas, Joseph, Robert S. Negrin, Sandra J. Horning, et al.. (2000). High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma. Biology of Blood and Marrow Transplantation. 6(3). 352–358. 42 indexed citations

12.

Damon, Lloyd E., Wendy Hu, Keith Stockerl‐Goldstein, et al.. (2000). High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: Experience in California. Biology of Blood and Marrow Transplantation. 6(5). 496–505. 12 indexed citations

13.

Cao, Thai M., Robert S. Negrin, Keith Stockerl‐Goldstein, et al.. (2000). Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation. 6(4). 387–394. 32 indexed citations

14.

Zhang, Yaou, Liu Cao, Chris Kiani, et al.. (1999). Promotion of chondrocyte proliferation by versican mediated by G1 domain and EGF-like motifs. Journal of Cellular Biochemistry. 73(4). 445–457. 58 indexed citations

15.

Zhang, Yaou, Liu Cao, Chris Kiani, et al.. (1999). Promotion of chondrocyte proliferation by versican mediated by G1 domain and EGF‐like motifs. Journal of Cellular Biochemistry. 73(4). 445–457. 1 indexed citations

16.

Cao, Liu, Vivian Lee, Mark E. Adams, et al.. (1999). β1-Integrin–collagen interaction reduces chondrocyte apoptosis. Matrix Biology. 18(4). 343–355. 98 indexed citations

17.

Leung, Ann N., et al.. (1999). Pulmonary Infections after Bone Marrow Transplantation: Clinical and Radiographic Findings. Radiology. 210(3). 699–710. 92 indexed citations

18.

Long, GD, M Amylon, Keith Stockerl‐Goldstein, et al.. (1997). Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.. PubMed. 3(6). 324–30. 35 indexed citations

19.

Horning, Sandra J., Nelson J. Chao, Robert S. Negrin, et al.. (1997). High-Dose Therapy and Autologous Hematopoietic Progenitor Cell Transplantation for Recurrent or Refractory Hodgkin's Disease: Analysis of the Stanford University Results and Prognostic Indices. Blood. 89(3). 801–813. 206 indexed citations

20.

Long, Gwynn D., Nelson J. Chao, Wendy Hu, et al.. (1996). High dose etoposide-based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myeloma. Cancer. 78(12). 2502–2509. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact